Project Grant R34DA063961
- Federal Grant Award Summary The National Institute on Drug Abuse awarded the University of Southern California a $196,236 Project Grant on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate clinician preconceptions about cannabis use during pregnancy and their impact on prenatal care quality. The award funds a five-year research initiative (through June 30, 2030) led by Dr. Rachel Carmen Ceasar that employs natural language processing and artificial...
- Grant Award Summary Michigan State University, in partnership with Henry Ford Health, received a $183,681 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 15, 2026, through February 28, 2031. The award funds the development and testing of a technology-based intervention designed to reduce prenatal cannabis use among pregnant patients. The project will employ Electronic Screening and Brief...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $730,649 Project Grant to the University of California, San Diego, effective May 1, 2026, through February 28, 2031. The project, titled "The Acute Effects of Cannabis Use on Parenting," delivers research services and data collection focused on understanding how cannabis use impacts parenting behavior among regular users with young...
- Federal Project Grant Award Summary The University of Washington received a $699,748 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded February 15, 2026, with completion targeted for November 30, 2030. This research initiative examines neurodevelopmental trajectories associated with prenatal cannabis exposure through a longitudinal study conducted at the Seattle campus. The project delivers comprehensive...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UCLA a $188,199 Project Grant effective April 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate a digital therapeutic intervention for individuals with comorbid anxiety disorders and alcohol or cannabis use disorders. The primary deliverable is a mobile application-based intervention titled Anxiety Management Treatment for Substance Use Disorders (AMT/SUD), which...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $171,822 on July 15, 2025, to the University of Maryland, Baltimore to conduct the "Effects of Prenatal and Postnatal Cannabis Use on Lactation and Maternal Bonding (LAMB)" study, funded under CFDA 93.279 (Drug Use and Addiction Research Programs). The research will investigate the effects of cannabis use during pregnancy and the postpartum period on maternal attachment,...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $182,249 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective July 15, 2025, through June 30, 2029. This award supports the implementation and evaluation of EMPWR (Empowering Pregnant Women Receiving Medications for Opioid Use Disorder), a digitally enhanced intervention designed to improve buprenorphine treatment retention among...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Texas Health Science Center at Houston a Project Grant of $761,367 under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, with a completion date of May 31, 2030. This translational research project aims to identify and validate fetal central nervous system-derived extracellular vesicles (CNS-EVs) as biomarkers for predicting neurodevelopmental effects...
- Federal Project Grant Summary Award Details: Funding Agency: National Institute on Drug Abuse (NIDA) Federal Grant Program: Drug Use and Addiction Research Programs (CFDA 93.279) Principal Awardee: The Pennsylvania State University Total Funding: $1,680,850 Award Date: August 1, 2025 Project Period: August 1, 2025 – May 31, 2030 Research Objectives and Deliverables: This longitudinal research project examines the developmental pathways linking prenatal and postnatal substance exposure (tobacco...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Southern California $750,511 on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and pilot test a brief mobile phone-based intervention targeting prenatal cannabis use. The three-year project, scheduled for completion on March 31, 2029, will deliver a motivational enhancement intervention combining evidence-based harm reduction and cognitive behavioral strategies designed to address cannabis use among pregnant women. The intervention will present accurate health information to correct misperceptions, provide instruction on identifying credible sources, and teach protective behavioral and distress tolerance skills as alternatives to cannabis use for managing physical and mental health symptoms during pregnancy. The project will be executed in two phases: an initial beta-testing phase involving 15 pregnant women in their first trimester to evaluate feasibility and acceptability through structured interviews, followed by a randomized controlled pilot trial to assess intervention efficacy. The research will be conducted at USC's Los Angeles campus and will incorporate feedback from subject matter experts and pregnant cannabis users to tailor content and procedures. This pilot study addresses the growing public health concern of prenatal cannabis use, which carries documented risks to fetal development and maternal health outcomes including depression and cannabis use disorder, despite guidance from the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists against such use.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $750.5k | 3/26/26 |